Related by context. All words. (Click for frequent words.) 62 clinicopathological 62 scintigraphic 62 differential gene expression 61 Subgroup analyzes 60 arthrography 60 chest radiographs 60 adnexal mass 60 gadolinium enhanced 60 colonoscopic 60 HER2 expression 60 transvaginal sonography 60 FDG PET CT 60 F FDG PET 60 femoral neck fracture 60 familial aggregation 60 metaplasia 60 antiangiogenic therapy 59 multivariate analyzes 59 thyroid carcinoma 59 #F FDG PET 59 plasma pharmacokinetics 59 transrectal ultrasound guided 59 HIV seropositive 59 tumorigenicity 59 multicentric 59 lipodystrophy syndrome 59 pathologic examination 59 cytologic 59 psychiatric comorbidity 59 oncological outcomes 59 IntroductionThe 59 transesophageal 59 sonographically guided 59 familial clustering 59 bone scintigraphy 59 sonographic evaluation 59 prognostic significance 59 adjuvant therapies 59 univariate analyzes 59 urothelial carcinoma 59 postoperative radiotherapy 59 etiologic 58 cranial irradiation 58 SLNB 58 nephron sparing surgery 58 adrenocortical 58 DHEA supplementation 58 hyperplastic 58 interobserver 58 metabolite concentrations 58 thiopurine 58 histologic findings 58 seropositivity 58 chlamydial infection 58 ultrasonographic 58 histologic subtype 58 subgroup analyzes 58 metabolomic profiles 58 posttreatment 58 histopathological 58 adrenalectomy 58 osteoid 58 serologic testing 58 antioxidant supplementation 58 thyrotropin 58 intact parathyroid hormone 58 urolithiasis 58 abnormal cytology 58 thyrotropin levels 57 premorbid 57 urodynamic parameters 57 multivariable analysis 57 gastric adenocarcinoma 57 authors conclude 57 microsatellite instability 57 sonographic diagnosis 57 convergent validity 57 adenomatous 57 prostate cancer CaP 57 histologic diagnosis 57 antiresorptive 57 tumor excision 57 primary aldosteronism 57 neurosensory 57 tumor histology 57 morphologic 57 maturational 57 metaanalysis 57 diffusion tensor 57 florbetaben 57 comorbid depression 57 mucinous 57 perinatal outcomes 57 BPS IC 57 prognostic variables 57 humoral responses 57 radiographic findings 57 logistic regression analyzes 57 histologic examination 57 antiangiogenic agents 57 meta regression 57 cardiac repolarization 57 hMG 57 hamartomas 57 nutrient supplementation 57 biologic plausibility 57 autonomic dysfunction 57 ventricular myocardium 57 Heritability 57 Cytogenetic 57 prospective multicenter study 57 vascularisation 57 clinicopathological features 57 functional gastrointestinal disorders 57 hypercoagulable 57 chronicity 57 anthropometric measurements 56 somatoform disorders 56 intravesical therapy 56 androgen suppression 56 refore 56 IOP lowering 56 attain statistical significance 56 intraobserver 56 baseline LDH 56 dosimetric 56 urography 56 renal cysts 56 laterality 56 oropharyngeal 56 ROC curves 56 bladder carcinoma 56 HbF 56 CEACAM1 56 postintervention 56 endoscopic ultrasonography 56 biochemical abnormalities 56 multiple logistic regression 56 multicenter trials 56 clinico pathological 56 GH deficiency 56 genotypic resistance 56 cervical lymph nodes 56 metastatic lymph nodes 56 poststroke depression 56 MMSE score 56 nodal metastases 56 RE LY trial 56 HepG2 cells 56 mTOR inhibition 56 mutated K ras 56 echogenicity 56 CORE OM 56 Histologic 56 immunostaining 56 transabdominal 56 radiochemotherapy 56 Kaplan Meier curves 56 LVNC 56 Multivariate logistic regression 56 histopathologic 56 renal tumors 56 nodal metastasis 56 myogenic cell 56 methodologic 56 intratympanic 56 serum lipid levels 56 p# biomarker 56 pituitary hormone 56 primary hyperparathyroidism 56 CP CPPS 56 clinicopathologic 56 psychiatric morbidity 56 HGPIN 56 adenoma detection 56 cellularity 56 residual confounding 56 cerebral oxygenation 56 murine models 56 S. maltophilia 56 incidentalomas 56 KRAS status 56 mammographic density 56 sonographic findings 56 preoperative diagnosis 56 ovarian malignancy 56 neuropsychological impairments 56 allogeneic HSCT 56 CIN2 + 55 pelvic lymphadenectomy 55 phytoestrogen intake 55 somatization disorder 55 antitumor effect 55 cervicitis 55 viral etiology 55 TNM staging 55 pharmacokinetic interactions 55 genomic biomarker 55 sonographic appearance 55 unicompartmental knee arthroplasty 55 phenotypic expression 55 myocardial viability 55 underdiagnosis 55 skeletal metastases 55 cytological 55 vertebral subluxation 55 hyperalgesia 55 immunotoxicity 55 neoplasias 55 HIV HCV coinfected 55 Topical corticosteroids 55 acetazolamide 55 lymphovascular invasion 55 oral anticoagulation 55 nonfasting triglyceride levels 55 multivariable adjusted 55 guideline concordant 55 gastric mucosa 55 EBUS FNA 55 CTEPH 55 percutaneous vertebroplasty 55 gonococcal 55 confounder 55 observational cohort study 55 β blockers 55 NATRECOR ® 55 T2DM 55 IPAH 55 DNA methylation patterns 55 #HT#A receptor 55 plain radiographs 55 pharmacodynamic PD 55 pathogenetic 55 spontaneous regression 55 aetiology 55 inhaled corticosteroid therapy 55 mammographically 55 MGUS 55 electrophysiologic 55 empiric 55 generalizability 55 haematologic 55 periprocedural MI 55 symptomatology 55 unmeasured confounders 55 etiological 55 vasoactive 55 sacral neuromodulation 55 oncologic outcomes 55 empiric therapy 55 psychopharmacologic 55 comorbid disorders 55 logistic regression model 55 histological subtype 55 artery stenosis 55 pleiotropic effects 55 syndromal 55 postdischarge 55 penetrance 55 Estrogen Receptor 55 prostate carcinoma 55 primary dysmenorrhoea 55 chemosensitivity 55 perfusion imaging 55 aetiological 55 carotid plaque 55 aminotransferase 55 cytoreductive nephrectomy 55 FDG PET imaging 55 pharmacogenetic testing 55 biliary tract cancer 55 renal scarring 55 bronchogenic carcinoma 55 neoplastic 55 anatomic abnormalities 55 pathophysiological mechanisms 55 Logistic regression analysis 55 urodynamic 55 mucosal inflammation 55 coexpression 55 prostatic tissue 55 femoral neck fractures 55 spirometric 55 mediated inhibition 55 Histopathologic 55 interstitial brachytherapy 55 liver metastasis 55 MRSA colonization 55 de novo mutations 55 radiotherapy RT 55 acetabular fractures 55 Zevalin consolidation 55 analgesic medications 55 Meta analyzes 55 retrospective cohort 55 estimated GFR 55 immunohistochemical analysis 55 hepatectomy 55 Tumor Response 55 carotid IMT 55 WOMAC scores 55 PSA nadir 55 stem cell transplantations 55 calcaneal fractures 55 hematopoietic cancers 55 microscopic hematuria 55 FGFR2 gene 55 albumin excretion 55 esophageal carcinoma 55 H pylori 55 FDG uptake 55 concurrent chemoradiation 55 alveolar epithelial cells 55 KRAS mutation 55 diagnostic modality 55 nonalcoholic steatohepatitis NASH 55 evolvability 55 schizophreniform disorder 55 microvascular dysfunction 55 potentiation 55 duplex ultrasonography 54 CYP#D# inhibitor 54 LV dysfunction 54 ultrastructural 54 erection hardness 54 CVD mortality 54 generalisability 54 serum PTH 54 pressor response 54 NCCN guidelines 54 melanocytic nevi 54 Mechanistic studies 54 immune reconstitution syndrome 54 T1DM 54 eculizumab therapy 54 chronic LBP 54 FDG-PET/CT 54 allelic 54 varicoceles 54 computed tomographic 54 probiotic supplementation 54 GnRH agonists 54 generalisable 54 antipsychotic prescribing 54 prostatic 54 aminotransferase levels 54 lymph node metastasis 54 MDRD 54 hepatic fibrosis 54 testicular tumors 54 Multivariate analyzes 54 extensive metabolizers 54 molecular determinants 54 ERalpha 54 echocardiographic parameters 54 cystoscopic 54 osteosarcomas 54 TOP2A gene 54 meta analytic 54 cortical atrophy 54 molecularly defined 54 thromboembolic disease 54 Symptom severity 54 atherogenesis 54 adjuvant systemic 54 microbiologic 54 serum homocysteine 54 vitamin D inadequacy 54 neurocognitive function 54 β1 54 electroencephalographic 54 Clinical Relevance 54 invasive carcinoma 54 Cardiotoxicity 54 pharmacologic treatments 54 detrusor 54 Histological 54 mediastinal lymph nodes 54 histologically proven 54 cortical activation 54 pharmacologic intervention 54 Combination antiretroviral therapy 54 bone grafting procedures 54 pathognomonic 54 myocardial function 54 APOE genotype 54 prostate carcinogenesis 54 SSc 54 histopathological examination 54 calculi 54 renoprotective 54 thyroid nodules 54 acetabular dysplasia 54 antibody titer 54 beta carotene supplementation 54 intracranial stenosis 54 bronchial epithelial cells 54 initiating antiretroviral therapy 54 genomewide 54 TOP2A 54 advanced adenoma 54 limiting generalizability 54 CSF biomarkers 54 antimicrobial prophylaxis 54 cardiogenic 54 neurodevelopmental outcomes 54 Adjuvant therapy 54 chemoprevention trials 54 prognostic indicators 54 papillary renal cell carcinoma 54 Kaplan Meier curve 54 tracheal intubation 54 pCR 54 transrectal ultrasonography 54 logistic regression models 54 Lymph node 54 SNP rs# [002] 54 histopathologic findings 54 gastric cardia 54 postnatally 54 serum estradiol 54 eNO 54 NIHSS score 54 completely resected 54 creatinine ratio 54 covariate 54 neurodevelopmental outcome 54 serum concentrations 54 homocysteine concentrations 54 angiographically 54 conventional DMARDs 54 physico chemical properties 54 clonal expansion 54 heritable variation 54 nitrotyrosine 54 noninfectious uveitis 54 EUS FNA 54 carcinomatosis 54 elevated IOP 54 pre malignant lesions 54 T1a 54 LNG IUS 54 immunohistochemical 54 Multiple logistic regression 54 stratifying patients 54 Chlamydia trachomatis infection 54 noncardiac 54 multiple linear regression 54 CI -#.# 54 metabolic dysfunction 54 hypoperfusion 54 EGFR mutation status 54 multifocal IOLs 54 serum urate levels 54 Schaffir 54 somatization 54 HIV seroprevalence 54 serologic tests 54 multivariate regression analysis 54 radioimmunotherapy RIT 54 nondiagnostic 54 conditional logistic regression 54 histological examination 54 clomipramine 54 ELISPOT 54 CPAP adherence 54 prophylactic cranial irradiation 54 Adverse effects 54 psychiatric comorbidities 54 morphologic characteristics 54 amisulpride 54 #,#-# [003] 54 venous thromboembolic disease 54 airway hyperresponsiveness 54 serum ALT 54 toxicologic 54 nonobese 54 developmental neurotoxicity 54 Randomized trials 54 atherothrombotic 54 epididymal 54 LRTI 54 interobserver reliability 54 subsyndromal 54 randomized controlled trials RCTs 54 neoadjuvant chemoradiotherapy 54 PLCO 54 nonrandomized studies 54 myocardial ischaemia 54 serum cortisol 54 radical prostatectomy RP 53 carcinoids 53 Leydig cell 53 OSAHS 53 relapsed AML 53 underlying pathophysiology 53 airway responsiveness 53 leiomyomas 53 germline mutations 53 predictive validity 53 ECLS 53 adrenal suppression 53 logistic regression analysis 53 hypogonadotropic hypogonadism 53 percutaneous biopsy 53 Helicobacter pylori infection 53 tumor subtype 53 miRs 53 thrombophilia 53 seminomas 53 nephrolithiasis 53 hormone receptor status 53 renal cell carcinomas 53 interindividual variability 53 postoperative radiographs 53 gastric carcinoma 53 audiometric 53 extramedullary 53 postoperative complication 53 IL 1ß 53 carotid bruit 53 EEG abnormalities 53 dobutamine stress 53 pT2 53 riociguat 53 dietary acrylamide 53 repolarization 53 radiographic examinations 53 gonococcal infection 53 colorectal carcinogenesis 53 immunomodulation 53 mechanistic studies 53 beta1 integrin 53 SCr 53 external beam radiotherapy 53 elevated transaminases 53 Genetic predisposition 53 pathogenic mechanisms 53 interobserver agreement 53 colorectal liver metastases 53 endometrial biopsy 53 isoproterenol 53 neuropathologic 53 etiologic factors 53 nonpsychiatric 53 indolent lymphomas 53 colorectal adenoma 53 cytoreductive surgery 53 prognostic indicator 53 EQ 5D 53 epoetin therapy 53 Protease Inhibitors 53 chronic periodontitis 53 natriuretic peptides 53 LHRH receptor positive 53 induced sputum 53 HIV seroconversion 53 intestinal metaplasia 53 bivariate 53 biopsychosocial model 53 serum lipid 53 curability 53 haematopoietic 53 splenic 53 coagulation abnormalities 53 underwent resection 53 malignant neoplasm 53 hydronephrosis 53 perioperative complications 53 body habitus 53 independent prognostic marker 53 parasitaemia 53 chlamydial 53 karyotypes 53 enucleation 53 osteopathic manipulation 53 biochemical recurrence 53 polytherapy 53 depressive symptomatology 53 intestinal permeability 53 N glycan 53 HIV lipodystrophy 53 liver transplant recipients 53 TT genotype 53 sociodemographic factors 53 TMPRSS2 ERG fusion 53 preoperative chemotherapy 53 Cochrane reviewers 53 ANCOVA 53 NHANES III 53 atherothrombotic disease 53 interrater reliability 53 H. pylori eradication 53 carotid plaques 53 genetic loci 53 urinary cadmium 53 Socioeconomic status 53 atrophic gastritis 53 neuropsychological impairment 53 intima media thickness 53 unsedated colonoscopy 53 distal radial fractures 53 osteochondroma 53 prognostically 53 perseverative 53 neuroleptic 53 surgical debulking 53 nasal polyposis 53 axillary dissection 53 viral kinetics 53 hippocampal atrophy 53 TURBT 53 contralateral breast 53 ascertainment bias 53 parkinsonian symptoms 53 transient elastography 53 topical NSAIDs 53 paroxysmal AF 53 STEP BD 53 multivariable analyzes 53 axillary node dissection 53 Pearson correlation coefficients 53 pairwise comparisons 53 serum folate concentrations 53 aromatase inhibitor therapy 53 photoprotection 53 pulmonary metastases 53 autoregulation 53 plasminogen activators 53 HRQOL 53 de novo AML 53 somatic mutations 53 coagulopathy 53 inotropic agents 53 perioperative morbidity 53 Immunohistochemical analysis 53 endometrial carcinoma 53 pharmacokinetic characteristics 53 TRUS biopsy 53 undergoing peritoneal dialysis 53 locoregional recurrence 53 APTIVUS r 53 nomograms 53 dimensional sonography 53 dichotomized 53 ureteral obstruction 53 confidence intervals CIs 53 missense mutations 53 comorbid anxiety 53 malignant phenotype 53 alexithymia 53 comorbid illnesses 53 observational cohort 53 morphometric vertebral fractures 53 pretest probability 53 cerebral angiography 53 radiographic outcomes 53 sociodemographic characteristics 53 atherosclerotic renal artery stenosis 53 serum creatinine levels 53 histopathologic diagnosis 53 intraductal 53 Pharmacologic 53 tracer uptake 53 labetalol 53 somatic symptoms 53 psychodynamic therapy 53 artifactual 53 inhibin B 53 impair fertility 53 parenchymal 53 murine model 53 pulmonary nodules 53 HER2 overexpression 53 multivitamin supplementation 53 cerebellar vermis 53 nephron 53 thyroid hormone levels 53 PET CT colonography 53 cyto 52 HNSCC 52 nonpregnant women 52 arterial thickening 52 colon resection 52 esophageal gastric 52 cystoid macular edema 52 TNF antagonist 52 utero exposure 52 postsurgical 52 pancreatectomy 52 nonmelanoma 52 urine cytology 52 ischemic mitral regurgitation 52 genes differentially expressed 52 extracranial 52 #β estradiol 52 perioperatively 52 teratogenic 52 TNF alpha inhibitor 52 HAART initiation 52 Aspergillus nidulans 52 immunological responses 52 p = .# [002] 52 trophoblast cells 52 colonography 52 genotypic 52 breast cancer subtypes 52 micrometastases 52 heterozygotes 52 LHRH agonists 52 rCBF 52 hypochondriasis 52 cTnI 52 retrospective observational study 52 nosology 52 Histologically 52 Multivariate analysis 52 CYP#D# genotype 52 glomerular filtration 52 morphological abnormalities 52 urothelium 52 titrated glipizide 52 immunocompetent 52 serum vitamin D 52 ± SEM 52 immunoreactive 52 serum uric acid 52 androgen deprivation 52 coinfected patients 52 pa tients 52 ConclusionThis 52 AST ALT 52 % CI #.#-#.# [008] 52 fig. S4 52 OPRM1 52 postoperative morbidity 52 univariate analysis 52 tertiles 52 mRNA expression 52 neurocognitive deficits 52 somatoform disorder 52 coinfection 52 pupillary 52 albumin excretion rate 52 orchitis 52 gene polymorphisms 52 PCa 52 RNFL thickness 52 guaiac 52 GI toxicity 52 neurocognitive impairment 52 ELBW infants 52 abnormal Pap smears 52 Logistic regression 52 PCWP 52 genetic polymorphism 52 esophageal squamous cell carcinoma 52 efficacy evaluable 52 thyroid nodule 52 ALI ARDS 52 adenoidectomy 52 EuroSCORE 52 rs# [004] 52 randomizing patients 52 lymph node dissection 52 mGluR5 inhibition 52 conformal radiotherapy 52 perfusion abnormalities 52 subcutaneous immunoglobulin 52 Radiographic 52 neutropenic patients 52 subtrochanteric 52 Univariate analysis 52 bicuspid aortic valves 52 chi squared 52 anastomotic leak 52 intracranial hypertension 52 prospective multicentre 52 SIADH 52 arteriography 52 peripheral insulin sensitivity 52 PET CT scanning 52 pharmacodynamic markers 52 postoperative chemotherapy 52 nonrandomized 52 Fig. 2a 52 lignan intake 52 antidepressive 52 pleiotropic 52 oral anticoagulant therapy 52 enhanced sonography 52 HF WBI 52 Lp lipoprotein 52 NHAMCS 52 neurodevelopmental impairment 52 CIN3 52 hyperplastic polyps 52 CR nPR 52 hemodilution 52 plasma cortisol 52 fluoroquinolone resistance 52 recurrent glioblastoma multiforme 52 Endometrial 52 pathophysiological 52 hyperhomocysteinemia 52 Randomized clinical trials 52 allele frequencies 52 ileal 52 overactive bladder symptoms 52 genomic alterations 52 redox active 52 Histopathological 52 sonographic 52 sociodemographic variables 52 androgen ablation 52 knee osteoarthritis OA 52 gynaecologic 52 cytopenia 52 pharmacological therapies 52 endoscopic retrograde 52 Radical prostatectomy 52 inactivated influenza vaccines 52 aortic insufficiency 52 transesophageal echocardiography 52 systolic function 52 urodynamic studies 52 etiologic agent 52 preoperative MRI 52 qRT PCR 52 Echocardiographic 52 BRCA2 mutation carriers 52 posttransplant 52 atopic sensitization 52 facial clefts 52 lymphadenectomy 52 pathophysiologic mechanisms 52 flavopiridol 52 chemoradiation therapy 52 hypovitaminosis D 52 correlational 52 RRM1 52 lamivudine resistant 52 Observational studies 52 pulmonary infiltrates 52 antitumor efficacy 52 helical CT 52 headache abdominal pain 52 sensory gating 52 imatinib therapy 52 transarterial 52 hepatic arterial 52 immunosuppressive regimen 52 hallux valgus 52 activating mutation 52 locoregional 52 adnexal masses 52 endoscopist 52 TKAs 52 Dr. Hovanesian 52 endothelial activation 52 NMDA antagonists 52 multivariate logistic regression 52 adenoma recurrence 52 mITT 52 immunocytochemistry 52 Prognostic factors 52 Velcade bortezomib 52 Supplementary Table 52 acute respiratory tract infections 52 multimodality therapy 52 digital subtraction angiography 52 resected pancreatic cancer 52 immunomodulatory effects 52 EBV infection 52 STAT4 52 chromosomal anomalies 52 antidepressant efficacy 52 aneuploid 52 socioeconomic status SES 52 vesicoureteral reflux 52 coronary CTA 52 corticosterone levels 52 acetabular fracture 52 submandibular gland 52 chromosome #p# [002] 52 researchers hypothesized 52 parous women 52 distal colon 52 serum IgE 52 poststroke 52 intra tumoral 52 mean ± SEM 52 miRNA expression 52 needle aspiration 52 Socio demographic 52 metachronous 52 nonvascular 52 prelicensure 52 prefrontal regions 52 4D imaging 52 axillary node 52 atopic disorders 52 serologic 52 intravenous cyclophosphamide 52 hepatic insufficiency 52 plasma lipid 52 hepatic lesions 52 G allele 52 coronary microvascular 52 undetectable HBV DNA 52 P. falciparum malaria 52 incomplete revascularization 51 histopathology 51 nonoperative treatment 51 SpHb monitoring 51 surgical biopsies 51 ovarian suppression 51 Genetic variation 51 cervical lesions 51 posttest 51 Erythropoietic 51 sequence homology 51 gastric distention 51 Breslow thickness 51 PLCO trial 51 cardioprotection 51 Ann Emerg Med 51 platelet activation 51 PCOD 51 reflux esophagitis 51 Triapine R 51 affective psychoses 51 TNF blocker therapy 51 histologically 51 methodologically rigorous 51 longitudinal observational study 51 embryonic lethality 51 prokinetic 51 FDG PET 51 neovascularisation 51 microvessel density 51 spinal metastases 51 stress echocardiography 51 immunoreactivity 51 asplenia 51 intraventricular 51 VATS lobectomy 51 diathesis 51 BCL#A 51 colon capsule endoscopy 51 colorectal neoplasms 51 multivariable logistic regression 51 antiplatelet therapies 51 ALA PDT 51 PFPS 51 syndromic 51 salivary flow 51 clinically evaluable 51 hepatorenal syndrome 51 erythrocyte sedimentation rate 51 neuronal dysfunction 51 haemodynamic 51 dinucleotide 51 symptomatic VTE 51 researchers hypothesize 51 Non inferiority 51 pulmonary dysfunction 51 RCTs 51 Conclusions 51 transmural 51 surgical excision 51 dyssynchrony 51 pituitary adenomas 51 fractional anisotropy 51 plasma folate 51 pharmacologic stress 51 % CI #.#-#.# [005] 51 nonadherence 51 parathyroidectomy 51 bivariate analyzes 51 xenobiotic 51 rebleeding 51 sociocultural context 51 concomitant AEDs 51 predictive biomarker 51 oesophageal adenocarcinoma 51 pathophysiologic 51 dimensional ultrasonography 51 genomic variation 51 dose dependently 51 Randomised controlled trials 51 subclinical disease 51 periprosthetic fracture 51 acromegalic patients 51 epistatic 51 cortisol secretion 51 PROCHYMAL 51 SCIg 51 bacteraemia